LONG $AZN Covid wave 2 play ($MRNA $GILD $INO $SPY)
see full chart at tradingview.com/u/WallSt007
AZN
Entry $54 area
Target $57
stoploss 53
Why this play?
Covid Vaccine stocks are hot right now, cases are rising = easy money.
What is AZN?
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology,
cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide.
The company serves primary care and specialty care physicians through distributors and local representative offices.
The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999.
AZN
Entry $54 area
Target $57
stoploss 53
Why this play?
Covid Vaccine stocks are hot right now, cases are rising = easy money.
What is AZN?
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology,
cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide.
The company serves primary care and specialty care physicians through distributors and local representative offices.
The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999.
If you appreciate my technical analysis and want to check out our
Free Newsletter --> diywallst.com/
Free Newsletter --> diywallst.com/
Publikasi terkait
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.
If you appreciate my technical analysis and want to check out our
Free Newsletter --> diywallst.com/
Free Newsletter --> diywallst.com/
Publikasi terkait
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.